Mill Capital Management’s AbbVie ABBV Stock Holding History

Mill Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$862K	Hold	3,297	–	–	0.06%	83
2026 Q2	$830K	Sell	3,297 -1,125	-25%	-$242K	0.06%	83
2026 Q1	$962K	Hold	4,422	–	–	0.07%	80
2025 Q4	$1.01M	Buy	4,422 +40	+0.9%	+$9.11K	0.07%	81
2025 Q3	$1.01M	Hold	4,382	–	–	0.08%	78
2025 Q2	$813K	Hold	4,382	–	–	0.06%	81
2025 Q1	$918K	Hold	4,382	–	–	0.07%	81
2024 Q4	$779K	Hold	4,382	–	–	0.06%	82
2024 Q3	$865K	Hold	4,382	–	–	0.07%	81
2024 Q2	$752K	Hold	4,382	–	–	0.06%	84
2024 Q1	$798K	Hold	4,382	–	–	0.07%	85
2023 Q4	$679K	Hold	4,382	–	–	0.06%	89
2023 Q3	$653K	Hold	4,382	–	–	0.06%	89
2023 Q2	$590K	Hold	4,382	–	–	0.06%	92
2023 Q1	$698K	Hold	4,382	–	–	0.07%	86
2022 Q4	$708K	Hold	4,382	–	–	0.08%	83
2022 Q3	$588K	Sell	4,382 -198	-4%	-$28.4K	0.07%	85
2022 Q2	$701K	Hold	4,580	–	–	0.08%	82
2022 Q1	$742K	Buy	4,580 +198	+5%	+$28.8K	0.07%	89
2021 Q4	$593K	Buy	+4,382	New	+$518K	0.06%	78

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Mill Capital Management's ABBV Position: Q3 2026 in Review

Mill Capital Management held its AbbVie (ABBV) position steady in Q3 2026 at 3,297 shares worth $862K. The position accounts for 0.06% of the portfolio, ranked #83.

Mill Capital Management first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.01M in Q3 2025. 2,194 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Mill Capital Management held 3,297 shares of AbbVie worth $862K as of Q3 2026.
Mill Capital Management left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.06% of Mill Capital Management's portfolio in Q3 2026, its #83 holding.
Mill Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
Mill Capital Management's AbbVie position peaked at $1.01M in Q3 2025.
2,194 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Mill Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.